Study background: The atypical antipsychotic aripiprazole is commonly coadministered with antidepressant drugs as an adjunctive treatment for depression. The goal of the current study was to assess the potential…
spectrometry (HPLC–MS/MS) method has been developed and validated for simultaneous monitoring of Aripiprazole and its active metabolite Dehydroaripiprazole in human plasma using aripiprazole-d8 as the internal standard…
communication, as well as the presence of restricted and repetitive behaviors. Risperidone and aripiprazole are most commonly used drugs for the treatment of irritability and aggressive behaviour in children with…
with schizophrenia taking first- or second-generation antipsychotic drugs may switch to treatment with Aripiprazole due to side effects. This atypical antipsychotic launched in Europe ... better reported safety profile…
chronic, common, and often comorbid. There is an unmet need in its treatment. Aripiprazole and hydroxyzine are well‑known therapeutic options used as monotherapy in clinics. They have different mechanisms ... objective…
simple, sensitive isocratic RP-LC method has been developed for the quantitative determination of aripiprazole in both bulk drug and pharmaceutical dosage forms, used as a typical antipsychotic drug ... using phosphoric…
derangement of glucose metabolism and an increase in body weight. Comparing to other antipsychotics, aripiprazole have better efficacy and better side effect profile, so we wanted to investigate whether ... glycemic…
prominent negative symptoms, who had an acute worsening of psychotic symptoms after initiation of aripiprazole. Worsened psychosis included prominent auditory hallucinations, persecutory delusions accompanied with…
Aripiprazole possesses a complex pharmacology with both partial agonist and full antagonist effects. The purpose of this article is to critically review, in the light of its unique receptor pharmacology ... current…
stability indicating reversed-phase liquid chromatographic method was developed for the quantitative determination of Aripiprazole and its related substances in bulk samples, pharmaceutical dosage forms in presence of…
present review was conducted to ascertain whether the combination of clozapine and aripiprazole may have a clinical role in patients partially responsive to clozapine monotherapy. We conducted a systematic review…
Abstract Objective: Given that aripiprazole acts as a partial agonist on the dopamine receptor, it may have unique effects on brain neuro-metabolism, specifically in the prefrontal cortex. In this ... exploratory study…
Aripiprazole is an atypical antipsychotic that acts as a partial agonist at dopamine D2 receptors. Compared to other atypical antipsychotics, aripiprazole has less metabolic side effects and is less likely…
intramuscular long-acting injectable (LAI) aripiprazole administered once a month as a single injection into the gluteal muscle is increasingly appreciated in the course of a long-term maintenance treatment…
observe the efficacy of modified electroconvulsive therapy in conjunction with aripiprazole and lorazepam in patients with schizophrenia. The study population for our research comprised 100 patients with schizophrenia…
function and capacity of adult patients with schizophrenia who received treatment with risperidone and aripiprazole. 100 adult patients with schizophrenia, aged 30 y or younger, were enrolled in this study ... treated…
option for patients, although the current options may require an oral overlap at initiation. Aripiprazole lauroxil is an LAI that offers multiple dosing options but requires oral treatment overlap during ... alternative…
Aripiprazole and Clozapine are classified as an Atypical Antipsychotics. Aripiprazole primarily used in the treatment of schizophrenia and bipolar disorder. Clozapine works by changing the actions of chemicals ... many…
weeks to once every three months—promise to reduce the incidence of nonadherence. ARISTADA™ (aripiprazole lauroxil; ALLAI) extended-release injectable suspension was approved by the U.S. Food and Drug Administration…
year old patient with recurrent schizoaffective psychosis was switched over from clozapine to aripiprazole monotherapy. Six weeks afterwards the otherwise asymptomatic patient presented herself with skin and scleral…
amount of weight on antipsychotics, switching to a less obesogenic agent is an option. Aripiprazole appears to cause less weight gain than many other antipsychotics. We report on changes ... disease, in thirty-three…
male with schizophrenia who had long-term catatonic stupor and was successfully treated with aripiprazole. The onset of his stupor manifested rapidly after experiencing prodromal symptoms for two months ... weeks) was…
Stearic acid nanoparticles loaded with Aripiprazole has been developed as a new therapeutic strategy to achieve its controlled release profile suitable for parenteral administration. Nanoparticles composed of different…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.